Zeo ScientifiX (ZEOX) Income from Discontinued Operations (2015 - 2016)
Zeo ScientifiX (ZEOX) posted Income from Discontinued Operations of $13561.0 for Q4 2016, up 126.38% on a QoQ basis from -$51414.0 in Q3 2016, and up 136.04% year-over-year from $5745.1 in Q4 2015.
Powered by 
Analysis
Zeo ScientifiX (ZEOX) Income from Discontinued Operations (2015 - 2016) Analysis & Trends
Zeo ScientifiX has reported Income from Discontinued Operations for 2 years, with the latest figure at $13561.0 in Q4 2016.
- On a quarterly basis, Income from Discontinued Operations rose 136.04% year-over-year to $13561.0 in Q4 2016; TTM through Oct 2016 was -$197154.0, a 2495.5% decrease from a year earlier, with the FY2016 full-year figure at -$197155.0, down 3210.75% from the prior year.
- Income from Discontinued Operations was $13561.0 for Q4 2016 at Zeo ScientifiX, up from -$51414.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was $19049.0 in Q3 2015, with the low at -$120038.0 in Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Zeo ScientifiX | 8.53 Mn | 6.69 Mn | 2.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2016 | 13,561.00 |
| Jul 31, 2016 | -51,414.00 |
| Apr 30, 2016 | -39,263.00 |
| Jan 31, 2016 | -120,038.00 |
| Oct 31, 2015 | -37,623.00 |
| Jul 31, 2015 | 19,049.00 |
| Apr 30, 2015 | 10,170.00 |
| Jan 31, 2015 | 808.00 |